Loading

Press Releases

Press Releases

  1. ProBioGen grants a license for human lymph node technology to TissUse for Multi-Organ-Chip applications

    PDF Download

  2. Merus N.V. Signs Commercial Multi-Product License for ProBioGen’s GlymaxX® ADCC Enhancement Technology

    PDF Download

  3. ProBioGen Will License GlymaxX® to Thermo Fisher Scientific for Use in Developing Allergy Diagnostics

    PDF Download

  4. ProBioGen And Eucodis Sign Agreement to Commercialize C-LiNK, A Novel Antibody Drug Conjugation Technology

    PDF Download

  5. ProBioGen in Biosimilar Deal with Bio Farma Indonesia

  6. Zymeworks Contracts ProBioGen for Bi-specific GlymaxX® Antibody Cell Line Development

    PDF Download

  7. ProBioGen Inks Another Commercial GlymaxX® License and Contract Manufacturing Service Agreement on Immuno-Oncology Antibody

    PDF Download